Cost‐Effectiveness of Increased Use of Dual Antiplatelet Therapy After High‐Risk Transient Ischemic Attack or Minor Stroke

Cost‐Effectiveness of Increased Use of Dual Antiplatelet Therapy After High‐Risk Transient Ischemic Attack or Minor Stroke

Background Rates of dual antiplatelet therapy (DAPT) after high‐risk transient ischemic attack or minor ischemic stroke (TIAMIS) are suboptimal. We performed a cost‐effectiveness analysis to characterize the parameters of a quality improvement (QI) intervention designed to increase DAPT use after TI...

Full description

Bibliographic Details
Main Authors: Paul M. Wechsler, Ankur Pandya, Neal S. Parikh, Junaid A. Razzak, Halina White, Babak B. Navi, Hooman Kamel, Ava L. Liberman
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute ischemic stroke
cost‐effectiveness analysis
dual antiplatelet therapy
quality improvement
transient ischemic attack
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.032808

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.123.032808

Similar Items